Q
Quanlie Yang
Publications - 2
Citations - 385
Quanlie Yang is an academic researcher. The author has contributed to research in topics: Gemcitabine & Cisplatin. The author has an hindex of 1, co-authored 2 publications receiving 244 citations.
Papers
More filters
Journal ArticleDOI
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Li Zhang,Yan Huang,Shaodong Hong,Yunpeng Yang,Gengsheng Yu,Jun Jia,Peijian Peng,Xuan Wu,Qing Lin,Xuping Xi,Jiewen Peng,Mingjun Xu,Dongping Chen,Xiaojun Lu,Rensheng Wang,Xiaolong Cao,Xiaozhong Chen,Zhixiong Lin,Jianping Xiong,Qin Lin,Conghua Xie,Zhihua Li,Jianji Pan,Jingao Li,Shixiu Wu,Yingni Lian,Quanlie Yang,Chong Zhao +27 more
TL;DR: Gemcitabine plus cisplatin prolongs progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma and is established as the standard first-line treatment option for this population.
Journal ArticleDOI
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
Shaodong Hong,Yaxiong Zhang,Gengsheng Yu,Peijian Peng,Jiewen Peng,Jun Jia,Xuan Wu,Yan Huang,Yunpeng Yang,Qing Lin,Xuping Xi,Mingjun Xu,Dongping Chen,Xiaojun Lu,Rensheng Wang,Xiaolong Cao,Xiaozhong Chen,Zhixiong Lin,Jianping Xiong,Qin Lin,Conghua Xie,Zhihua Li,Jianji Pan,Jin-Gao Li,Shixiu Wu,Yingni Lian,Quanlie Yang,Chong Zhao,Wenfeng Fang,Li Zhang +29 more
TL;DR: The first randomized, phase III study of systemic chemotherapy in recurrent or metastatic nasopharyngeal carcinoma (NPC) was reported in this article, where the authors showed that systemic chemotherapy improved the survival of NPC patients.